Sakurai M - Search Results

1

Synergistic interaction between etoposide and 1-beta-D-arabinofuranosylcytosine.

Ohkubo T, Hori H, Higashigawa M, Kawasaki H, Kamiya H, Sakurai M, Kagawa Y, Kakito E, Sumida K, Ooi K. Ohkubo T, et al. Among authors: sakurai m. Adv Exp Med Biol. 1989;253B:355-62. doi: 10.1007/978-1-4684-5676-9_52. Adv Exp Med Biol. 1989. PMID: 2610123

2

Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.

Higashigawa M, Ido M, Nagao Y, Kuwabara H, Hori H, Ohkubo T, Kawasaki H, Sakurai M. Higashigawa M, et al. Among authors: sakurai m. Leuk Res. 1991;15(8):675-81. doi: 10.1016/0145-2126(91)90069-6. Leuk Res. 1991. PMID: 1895749

3

Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.

Higashigawa M, Ido M, Kuwabara H, Hori H, Ohkubo T, Kawasaki H, Sakurai M, Taniguchi K, Hamazaki M. Higashigawa M, et al. Among authors: sakurai m. Leuk Res. 1991;15(4):255-62. doi: 10.1016/0145-2126(91)90128-g. Leuk Res. 1991. PMID: 2030607

4

[Etoposide-induced deoxyribonucleic acid (DNA) damage and its effects on nucleotide pools in murine leukemia L1210 cells].

Ooi K, Ohkubo T, Kawasaki H, Sakurai M. Ooi K, et al. Among authors: sakurai m. Yakugaku Zasshi. 1990 Sep;110(9):673-7. doi: 10.1248/yakushi1947.110.9_673. Yakugaku Zasshi. 1990. PMID: 2262879 Japanese.

5

Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.

Higashigawa M, Hori H, Ohkubo T, Kawasaki H, Yoshizumi T, Sakurai M. Higashigawa M, et al. Among authors: sakurai m. Med Oncol Tumor Pharmacother. 1990;7(4):223-6. doi: 10.1007/BF02987099. Med Oncol Tumor Pharmacother. 1990. PMID: 2283889

6

Intracellular pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.

Higashigawa M, Hori H, Ochiai H, Ohkubo T, Kawasaki H, Nobori T, Kamiya H, Sakurai M. Higashigawa M, et al. Among authors: sakurai m. Adv Exp Med Biol. 1989;253B:341-8. doi: 10.1007/978-1-4684-5676-9_50. Adv Exp Med Biol. 1989. PMID: 2610121 No abstract available.

7

Relationship between intracellular dCTP/ara-CTP ratio and cytotoxic effect of ara-C.

Kawasaki H, Higashigawa M, Ohkubo T, Kamiya H, Sakurai M. Kawasaki H, et al. Among authors: sakurai m. Adv Exp Med Biol. 1989;253B:369-74. doi: 10.1007/978-1-4684-5676-9_54. Adv Exp Med Biol. 1989. PMID: 2610125 No abstract available.

8

Incorporation of N4-behenoyl-1-beta-D-arabinofuranosylcytosine into DNA as 1-beta-D-arabinofuranosylcytosine.

Higashigawa M, Ochiai H, Ohkubo T, Kawasaki H, Nobori T, Kamiya H, Sakurai M. Higashigawa M, et al. Among authors: sakurai m. Med Oncol Tumor Pharmacother. 1988;5(4):265-71. Med Oncol Tumor Pharmacother. 1988. PMID: 2848163

9

Increased sensitivity to 1-beta-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide.

Higashigawa M, Ido M, Ohkubo T, Kawasaki H, Kamiya H, Sakurai M, Taniguchi K, Hamazaki M. Higashigawa M, et al. Among authors: sakurai m. Leuk Res. 1989;13(1):39-42. doi: 10.1016/0145-2126(89)90029-5. Leuk Res. 1989. PMID: 2915574

10

Sequence-dependent antitumor effect of VP-16 and 1-beta-D-arabinofuranosylcytosine in L1210 ascites tumor.

Ohkubo T, Higashigawa M, Kawasaki H, Kamiya H, Sakurai M, Kagawa Y, Kakito E, Sumida K, Ooi K. Ohkubo T, et al. Among authors: sakurai m. Eur J Cancer Clin Oncol. 1988 Dec;24(12):1823-8. doi: 10.1016/0277-5379(88)90092-2. Eur J Cancer Clin Oncol. 1988. PMID: 3220079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,149 results

Search Page

Filters